Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

May 06, 2020 10:00 AM - May 07, 2020 4:45 PM

(Eastern Standard Time)

Fort Washington, PA 19034

Medical Affairs and Scientific Communications Forum

The Mysterious Regulatory Landscape in China: a Medical Writer’s Perspective

Session Chair(s)

Ruggero  Galici, PhD

Ruggero Galici, PhD

Director, Nonclinical and Clinical Pharmacology Writing

Alexion Pharmaceuticals, AstraZeneca Rare Disease, United States

This session will provide an overview of the dynamic regulatory environment to support the clinical development of pharmaceutical products in China. Preparation of common and unique medical writing documents to support regulatory submissions will be discussed.

Learning Objective :

At the conclusion of this session, participants should be able to:

  • Discuss the Chinese regulatory environment for pharmaceuticals
  • Recognize common and unique requirements for regulatory submissions to the Chinese National Medical Products Administration (NMPA)
  • Identify specific clinical documents for submissions to the NMPA

Speaker(s)

Hongbo  Zhu, PhD

The Mysterious China Regulatory Environment: Considerations in Clinical Development, Regulatory Submissions, and Medical Writing in China

Hongbo Zhu, PhD

Pfizer, Inc., China

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.